Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Sheinfeld

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Clinical outcome and predictors of survival in late relapse of germ cell tumorDavid S Sharp, Brett S Carver, Scott E Eggener, et al.
Cancer|July 29, 2010
Evaluation of lymph node counts in primary retroperitoneal lymph node dissectionR Houston Thompson, Brett S Carver, George J Bosl, et al.
Urology|November 7, 2016
Bilateral Testicular Germ Cell Tumors in the Era of Multimodal TherapyRyan P Kopp, Michael Chevinsky, Melanie Bernstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapyG Varuni Kondagunta, Joel Sheinfeld, Madhu Mazumdar, et al.
Urology|November 27, 2010
Contemporary lymph node counts during primary retroperitoneal lymph node dissectionR Houston Thompson, Brett S Carver, George J Bosl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladderGuido Dalbagni, Paul Russo, Bernard Bochner, et al.
Clinical Genitourinary Cancer|September 22, 2024
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node DissectionFady Baky, Nicole Liso, Brandon Williams, et al.
Urology|March 20, 2010
The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancerBrett S Carver, Angel M Cronin, Scott Eggener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapyEllen A Ronnen, G Varuni Kondagunta, Jennifer Bacik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2007
Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumorsBrett S Carver, Angel M Serio, Dean Bajorin, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Clinical outcome and predictors of survival in late relapse of germ cell tumorDavid S Sharp, Brett S Carver, Scott E Eggener, et al.
Cancer|July 29, 2010
Evaluation of lymph node counts in primary retroperitoneal lymph node dissectionR Houston Thompson, Brett S Carver, George J Bosl, et al.
Urology|November 7, 2016
Bilateral Testicular Germ Cell Tumors in the Era of Multimodal TherapyRyan P Kopp, Michael Chevinsky, Melanie Bernstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapyG Varuni Kondagunta, Joel Sheinfeld, Madhu Mazumdar, et al.
Urology|November 27, 2010
Contemporary lymph node counts during primary retroperitoneal lymph node dissectionR Houston Thompson, Brett S Carver, George J Bosl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladderGuido Dalbagni, Paul Russo, Bernard Bochner, et al.
Clinical Genitourinary Cancer|September 22, 2024
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node DissectionFady Baky, Nicole Liso, Brandon Williams, et al.
Urology|March 20, 2010
The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancerBrett S Carver, Angel M Cronin, Scott Eggener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapyEllen A Ronnen, G Varuni Kondagunta, Jennifer Bacik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2007
Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumorsBrett S Carver, Angel M Serio, Dean Bajorin, et al.
Pageof 12